No Data
No Data
Catalyst Watch: Spotlight on Tesla, Alphabet Earnings, AACR Drug Data, and Global PMI Reports
Hikma Acquires Rights to Generic Version of Novartis' Mekinist
Trump Targets Medicare Price Negotiations in New Executive Order
Tariffs Threaten Generic Drug Production and Supply - Fmr. FDA Commissioner
BNP Paribas Initiates Novartis at Outperform Rating, $116 Price Target
Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke